These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34558620)

  • 1. The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China.
    Zhao X; Li J; Liu F; Zhu P; Jiang L; Tang X; Xu J; Song Y; Chen J; Qiao S; Yang Y; Gao R; Xu B; Han Y; Yuan J
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):812-820. PubMed ID: 34558620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World.
    Yan K; Zhu P; Tang X; Li Y; Li J; Yuan D; Yang W; Yang Y; Gao R; Xu B; Yuan J; Zhao X
    J Atheroscler Thromb; 2023 Aug; 30(8):1057-1069. PubMed ID: 37258235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Value of the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy Score in Predicting Long-Term Major Adverse Cardiovascular And Cerebrovascular Events and Major Bleeding in Acute Coronary Syndrome Patients Who Underwent Percutaneous Coronary Intervention.
    Celik A; Esin FK; Emren SV; Kiris T; Karaca M
    Angiology; 2023; 74(10):958-969. PubMed ID: 36113050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation].
    Xu JJ; Zhu P; Song Y; Yuan DS; Jia SD; Zhao XY; Yao Y; Jiang L; Xu N; Li JX; Zhang Y; Song L; Gao LJ; Chen JL; Qiao SB; Yang YJ; Xu B; Gao RL; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):450-457. PubMed ID: 35589593
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benefits and risks of prolonged dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent in patients with stable coronary artery disease and diabetes].
    Cui KY; Yin D; Feng L; Zhu CG; Song WH; Wang HJ; Jia L; Zhang D; Yuan S; Wu SY; He JN; Qiao Z; Dou KF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):458-465. PubMed ID: 35589594
    [No Abstract]   [Full Text] [Related]  

  • 7. The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis.
    Clifford CR; Boudreau R; Visintini S; Orr N; Fu AYN; Malhotra N; Barry Q; So DYF
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):511-518. PubMed ID: 34849686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
    Valgimigli M; Smits PC; Frigoli E; Bongiovanni D; Tijssen J; Hovasse T; Mafragi A; Ruifrok WT; Karageorgiev D; Aminian A; Garducci S; Merkely B; Routledge H; Ando K; Diaz Fernandez JF; Cuisset T; Nesa Malik FT; Halabi M; Belle L; Din J; Beygui F; Abhyankar A; Reczuch K; Pedrazzini G; Heg D; Vranckx P;
    Eur Heart J; 2022 Sep; 43(33):3100-3114. PubMed ID: 35580836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
    Costa F; Van Klaveren D; Feres F; James S; Räber L; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M;
    J Am Coll Cardiol; 2019 Feb; 73(7):741-754. PubMed ID: 30784667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis.
    Munafò AR; Montalto C; Franzino M; Pistelli L; Di Bella G; Ferlini M; Leonardi S; D'Ascenzo F; Gragnano F; Oreglia JA; Oliva F; Ortega-Paz L; Calabrò P; Angiolillo DJ; Valgimigli M; Micari A; Costa F
    Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):709-721. PubMed ID: 37634083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients.
    Han J; Zhang Y; Shi X; Lin B; Zhang Y; Zhang R; Wang Y; Yan J; Lin Y
    Glob Heart; 2023; 18(1):11. PubMed ID: 37228657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline.
    Wang HY; Dou KF; Wang Y; Yin D; Xu B; Gao RL
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):663-675. PubMed ID: 32601780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study.
    Wester A; Mohammad MA; Olivecrona G; Holmqvist J; Yndigegn T; Koul S
    J Am Heart Assoc; 2021 Oct; 10(20):e020974. PubMed ID: 34612051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Asif A; Sezer A; Thoma F; Toma C; Schindler J; Fowler J; Smith C; Marroquin OC; Mulukutla SR
    Catheter Cardiovasc Interv; 2021 Nov; 98(5):838-845. PubMed ID: 33300267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry.
    Ueshima D; Ashikaga T; Yoshikawa S; Sasaoka T; Hatano Y; Kurihara K; Maejima Y; Isobe M
    J Cardiol; 2017 Jun; 69(6):815-822. PubMed ID: 27692568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI.
    Dannenberg L; Afzal S; Czychy N; M'Pembele R; Zako S; Helten C; Mourikis P; Zikeli D; Ahlbrecht S; Trojovsky K; Benkhoff M; Barcik M; Wolff G; Zeus T; Kelm M; Polzin A
    Int J Cardiol Heart Vasc; 2021 Apr; 33():100750. PubMed ID: 33763519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI.
    Wang HY; Xu B; Song CX; Guan CD; Xie LH; Zhao YY; Cai ZX; Yuan S; Dou KF
    J Interv Cardiol; 2022; 2022():3895205. PubMed ID: 35095347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
    Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
    Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI.
    Wang HY; Gao RL; Xu B; Yang YJ; Yin D; Wang Y; Dou KF
    Platelets; 2021 May; 32(4):533-541. PubMed ID: 32498587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'target trial'.
    Pufulete M; Harris J; Pouwels K; Reeves BC; Lasserson D; Loke YK; Mumford A; Mahadevan K; Johnson TW
    Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.